Yu, K., Cao, Y., Zhang, Z., Wang, L., Gu, Y., Xu, T., Zhang, X., Guo, X., Shen, Z., Qin, J.

Background
Gastric cancer (GC) remains a major global health burden. Despite the advancements in immunotherapy for patients with GC, the heterogeneity of GC limits response rates, especially in immune “cold” subtypes, including genomically stable and …